AVXL Anavex Life Sciences
- 9.460
- +0.430+4.76%
- 9.420
- -0.040-0.42%
Anavex Life Sciences News
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Donhauser Peter D.O.
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Thomas Steffen
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Skarpelos Athanasios
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Ma Jiong
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Velden Claus Vander
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Thomas Steffen
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Donhauser Peter D.O.
Anavex Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.31%)
Anavex Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.1%)
Anavex Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(4.44%)
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Ma Jiong
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Thomas Steffen
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Velden Claus Vander
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Donhauser Peter D.O.
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Skarpelos Athanasios
Anavex Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.32%)
Analysis
Price Target
No Data
No Data